ArticleInterdisciplinary sciences, computational life sciences2026
Musical Peptide: Fragmentation of Musical Protein for AI-driven Bioactive Peptide Discovery Based on a New DeepPepQSAR Pipeline.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Musical protein (MPro), the protein defined by music (namely biologization of music), is a reverse operation of the traditional life music that addresses the sonification of biomolecule to musical audio. We previously described a computational strategy for MPro facilitation, which maps the time sequence of music onto the spatial architecture of protein. Here, we further extend MPro to musical peptide (MPep) by fragmentizing MPro protein at either music time sequence level or protein residue sequence level, which represents a new technique to de novo generate distinct peptidic big data with intra-sequence organization, thus particularly suitable for AI-oriented tasks. On the other side, DeepPepQSAR methodology is raised as an integration of deep learning and traditional peptide quantitative structure-activity relationship (PepQSAR) in big-data bioactive peptide discovery, and we herein practice it on AI-driven high-throughput antimicrobial peptide (AMP) screening. Both the structural properties of length-varying peptide sequences and the bacterial species tested for these peptides are visually characterized by using PepImage representation, which is then fed into a dual-path convolutional neural network (CNN) to train a predictive DeepPepQSAR regression scoring function for further discovering potent AMPs from millions of MPep candidates. Consequently, 32 MPep peptides are identified to have a potential antibacterial profile, in which 4 and 12 peptides exhibit high and moderate activities, respectively, that are generally comparable with the sophisticated AMP peptide KR-12, but lower than the FDA-approved antibiotic Levofloxacin.
Indexed as
Identifiers
42870192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.